Live Price
Live Volume
Biohaven Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $14.87 |
|---|---|
| Close | $14.80 |
| Low | $14.60 |
| Low Change | -0.27 (-1.80%) |
| High | $14.87 |
| High Change | +0.00 (+0.00%) |
| Range | $0.27 |
| Volume | 349.667K |
| Dollar Volume | $5.18M |
Regular Trading Hours Yesterday
| Open | $14.42 |
|---|---|
| Close | $14.87 |
| Low | $14.22 |
| Low Change | -0.20 (-1.39%) |
| High | $14.97 |
| High Change | +0.55 (+3.81%) |
| Range | $0.75 |
| Volume | 2.037M |
| Dollar Volume | $30.29M |
Premarket Yesterday
| Open | $14.20 |
|---|---|
| Close | $14.25 |
| Low | $14.15 |
| Low Change | -0.05 (-0.35%) |
| High | $14.32 |
| High Change | +0.12 (+0.85%) |
| Range | $0.17 |
| Volume | 32.63K |
| Dollar Volume | $464.98K |
Biohaven News
2 weeks agoinvesting.comWhy is Biohaven Pharmaceutical stock sliding today?
2 weeks agoinvesting.comBiohaven stock tumbles after pausing trial enrollment
2 weeks agobarrons.comBiohaven Stock Is Sinking. Epilepsy Drug Trial Roadblock Is Only the Latest Blow.
2 weeks agoinvesting.comBiohaven Pharma stock falls after RBC Capital downgrade
1 month agoinvesting.comWhy is Biohaven Pharmaceutical stock sliding today?
1 month agoinvesting.comBiohaven stock surges 7% on SK Biopharmaceuticals deal
1 month agoinvesting.comSK Biopharmaceuticals signs epilepsy drug licensing deal with Biohaven
2 months agoinvesting.comWhy is Biohaven Pharmaceutical stock gaining today?
4 months agoinvesting.comBiohaven stock jumps on positive drug trial results
6 months agoinvesting.comBiohaven stock rises as obesity trial completes enrollment
Biohaven Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Biohaven Moving Averages
| 5 Day Moving Average (SMA5) | $13.72 |
|---|---|
| 10 Day Moving Average (SMA10) | $13.40 |
| 20 Day Moving Average (SMA20) | $14.50 |
| 50 Day Moving Average (SMA50) | $14.37 |
| 100 Day Moving Average (SMA100) | $13.15 |
| 200 Day Moving Average (SMA200) | $11.93 |
Biohaven Statistics
| Average Volume (30 Days) | 3.39M |
|---|---|
| P/E Ratio (Current) | -3.66 |
| EPS (Current) | -$3.89 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$511.87M |
| Cash Ratio | 3.80 |
| Current Ratio | 4.73 |
| Quick Ratio | 4.73 |
| Debt to Equity | 21.23 |
| Enterprise Value | $2.17B |
| EV to EBITDA | -3.89 |
| EV to Sales | — |
| Price to Book | 175.74 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.58% |
| Return on Equity | -48.02% |
Biohaven Stock Splits
There have been no stock splits for Biohaven (BHVN).
Biohaven Dividends
There have been no dividends for Biohaven (BHVN).